OPKO Health, Inc. is a healthcare company that engages in the diagnostics and pharmaceuticals businesses. The company’s Diagnostics segment operates Bio Reference Laboratories, which offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases. The company’s Pharmaceuticals segment focuses on the development and commercialization of pharmaceutical products for various medical indications.
The company has a market capitalization of $6.84 billion and an enterprise value of $7.07 billion. The stock has a 52-week low of $2.51 and a 52-week high of $10.43. The company reported revenue of $1.21 billion for the fiscal year ended December 31, 2018, an increase of 22.3% compared to the prior year. The company’s net income for the fiscal year was $146 million, or $0.68 per share, an increase of 43.5% compared to the prior year.
Company’s revenue for the quarter
The company’s revenue for the quarter ended March 31, 2019, was $314 million, an increase of 28.8% compared to the same period last year. The company’s net income for the quarter was $41 million, or $0.19 per share, an increase of 50.0% compared to the same period last year. OPKO Health is scheduled to release its next earnings report on August 8th, 2019. Analysts expect the company to report earnings of $0.21 per share, with a revenue estimate of $326.10 million.
OPKO Health, Inc. has received a consensus rating of “Buy” from the nineteen analysts that are presently covering the company, Market beat reports. One research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and ten have issued a buy recommendation on the company. The average 12-month target price among analysts that have covered the stock in the last year is $7.50.
Shares of OPKO Health
Shares of OPKO Health traded up $0.12 during midday trading on Monday, hitting $3.22. The stock had a trading volume of 22,183,428 shares, compared to its average volume of 25,710,000. The company has a quick ratio of 1.71, a current ratio of 2.10 and a debt-to-equity ratio of 0.73. OPKO Health has a fifty-two week low of $2.51 and a fifty-two week high of $10.43. The stock has a market capitalization of $6.84 billion, an enterprise value of $7.07 billion and a price-to-earnings ratio of -11.59.
OPKO Health (NYSE:OPK) last issued its quarterly earnings
OPKO Health (NYSE:OPK) last issued its quarterly earnings data on May 9th, 2019. The healthcare company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.06). The company had revenue of $308.60 million during the quarter, compared to analyst estimates of $313.10 million. OPKO Health had a negative return on equity of 7.68% and a negative net margin of 13.89%. The firm’s revenue for the quarter was up 28.8% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.03) EPS. On average, analysts expect that OPKO Health will post -0.16 earnings per share for the current fiscal year.”
OPKO health stock forecast price news analysis earnings report rating target recommendation buy sell hold shares trading volume market capitalization enterprise value quick ratio current ratio debt-to-equity ratio return on equity net margin revenue growth OPKO health.